On Friday, Metagenomi Inc (NASDAQ: MGX) opened at On Friday, higher 4.22% from the last session, before settling in for the closing price of $1.66. Price fluctuations for MGX have ranged from $1.23 to $6.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted -3.60% at the time writing. With a float of $21.78 million, this company’s outstanding shares have now reached $37.38 million.
Let’s look at the performance matrix of the company that is accounted for 202 employees. In terms of profitability, gross margin is 100.0%, operating margin of -193.73%, and the pretax margin is -184.18%.
Metagenomi Inc (MGX) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Metagenomi Inc is 41.73%, while institutional ownership is 24.90%. The most recent insider transaction that took place on Mar 05 ’25, was worth 1,744. In this transaction an insider of this company sold 930 shares at a rate of $1.87, taking the stock ownership to the 9,467 shares. Before that another transaction happened on Mar 05 ’25, when Company’s Chief Financial Officer sold 1,808 for $1.87, making the entire transaction worth $3,390. This insider now owns 59,684 shares in total.
Metagenomi Inc (MGX) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.6 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -3.60% per share during the next fiscal year.
Metagenomi Inc (NASDAQ: MGX) Trading Performance Indicators
Check out the current performance indicators for Metagenomi Inc (MGX). In the past quarter, the stock posted a quick ratio of 5.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.43.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.10, a number that is poised to hit -0.62 in the next quarter and is forecasted to reach -2.08 in one year’s time.
Technical Analysis of Metagenomi Inc (MGX)
Metagenomi Inc (NASDAQ: MGX) saw its 5-day average volume 0.39 million, a negative change from its year-to-date volume of 0.68 million. As of the previous 9 days, the stock’s Stochastic %D was 30.40%. Additionally, its Average True Range was 0.13.
During the past 100 days, Metagenomi Inc’s (MGX) raw stochastic average was set at 18.05%, which indicates a significant decrease from 42.42% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 54.28% in the past 14 days, which was lower than the 80.23% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.5796, while its 200-day Moving Average is $2.2575. Nevertheless, the first resistance level for the watch stands at $1.8000 in the near term. At $1.8700, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.9300. If the price goes on to break the first support level at $1.6700, it is likely to go to the next support level at $1.6100. The third support level lies at $1.5400 if the price breaches the second support level.
Metagenomi Inc (NASDAQ: MGX) Key Stats
There are currently 37,381K shares outstanding in the company with a market cap of 64.67 million. Presently, the company’s annual sales total 52,300 K according to its annual income of -78,060 K. Last quarter, the company’s sales amounted to 4,130 K and its income totaled -25,040 K.
